No registrations found.
ID
Source
Brief title
Health condition
Pulmonary embolism, deep venous thrombosis, venous thromboembolic disease, COVID-19
Sponsors and support
Intervention
Outcome measures
Primary outcome
The percentage of preventable CTPA in the work up of suspected PE in COVID-19 positive patients.
Secondary outcome
The percentage of preventable CTPA in the work up of suspected PE in COVID-19 positive patients. This percentage will be correlated to clinical parameters such as admission ward and early warning score.
Background summary
The objective of this study is to investigate whether point-of-care performed two-point CUS (2CUS) of both legs reduces the need for CTPA in COVID-19 patients.
Study objective
In non-COVID-19 patients with pulmonary embolism a prevalence of up to 70% of concomitant symptomatic or asymptomatic deep venous thrombosis has been reported. Physicians experience an exceptionally high prevalence of pulmonary embolism in COVID-19 patients. If the etiology is equal for COVID-19 and non-COVID-19, then numerous patients with COVID-19 and pulmonary embolism should have concomitant symptomatic or asymptomatic deep venous thrombosis.
Study design
none
Inclusion criteria
All patients with PCR confirmed COVID-19 with a clinically suspected pulmonary embolism, aged 18 years or over.
Exclusion criteria
chronic and known deep vein thrombosis (DVT), ipsi- or contralateral DVT within the previous 6 months, pregnancy
Design
Recruitment
IPD sharing statement
Followed up by the following (possibly more current) registration
No registrations found.
Other (possibly less up-to-date) registrations in this register
No registrations found.
In other registers
| Register | ID |
|---|---|
| NTR-new | NL8625 |
| Other | METC Utrecht : 20-292 |